Pharmather Holdings Ltd. (PHRRF)

[Skiluc]

Um. How does the sale of a fragment of IP and advancement of that IP not have anything to do with Pharamther? People know where it came from. Hello? Did we get paid in crackers? Now and into future? And we have more IP folks!! Notice our FDA phase 2 approval today. On Ketamine. Kinda a big deal. No?

It has everything to do with now. The bitoech sector is exploding! And an entire section of another companies advancement is dedicated to PHRM/PHRRF deal. Um. We still have all those fruits! As well as some fruits of the future as well.

Also, Revive is working with the University of Wisconsin to evaluate psilocybin as a potential treatment of methamphetamine use disorder and it recently submitted an application with the U.S. Food and Drug Administration ("FDA") to receive Orphan Drug Designation ("ODD") for psilocybin to treat traumatic brain injury, based in part of the research program acquired from PharmaTher Holdings Ltd. (CSE: PHRM) (OTCQB: PHRRF).